CA2446662A1 - Facteur de virulence var o du plasmodium falciparum - Google Patents

Facteur de virulence var o du plasmodium falciparum Download PDF

Info

Publication number
CA2446662A1
CA2446662A1 CA002446662A CA2446662A CA2446662A1 CA 2446662 A1 CA2446662 A1 CA 2446662A1 CA 002446662 A CA002446662 A CA 002446662A CA 2446662 A CA2446662 A CA 2446662A CA 2446662 A1 CA2446662 A1 CA 2446662A1
Authority
CA
Canada
Prior art keywords
lys
asn
glu
asp
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002446662A
Other languages
English (en)
Inventor
Odile Puijalon
Cecile Le Scanf
Anne Lavergne
Graham Bentley
Cyril Badaut
Sebastien Igonet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002409897A external-priority patent/CA2409897A1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to CA002446662A priority Critical patent/CA2446662A1/fr
Publication of CA2446662A1 publication Critical patent/CA2446662A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA002446662A 2002-10-25 2003-10-24 Facteur de virulence var o du plasmodium falciparum Abandoned CA2446662A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002446662A CA2446662A1 (fr) 2002-10-25 2003-10-24 Facteur de virulence var o du plasmodium falciparum

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002409897A CA2409897A1 (fr) 2002-10-25 2002-10-25 Facteur de virulence var o du plasmodium falciparum
CA2,409,897 2002-10-25
CA002446662A CA2446662A1 (fr) 2002-10-25 2003-10-24 Facteur de virulence var o du plasmodium falciparum

Publications (1)

Publication Number Publication Date
CA2446662A1 true CA2446662A1 (fr) 2004-04-25

Family

ID=32471123

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002446662A Abandoned CA2446662A1 (fr) 2002-10-25 2003-10-24 Facteur de virulence var o du plasmodium falciparum

Country Status (1)

Country Link
CA (1) CA2446662A1 (fr)

Similar Documents

Publication Publication Date Title
AU714484B2 (en) Human vascular endothelial growth factor 2
Baruch et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes
KR100391227B1 (ko) 인체의 프로그램화 된 세포사멸과 관련있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE69838254T2 (de) Zwei menschliche g-protein-gekoppelte rezeptorproteine: ebv-induzierter gpcr2 (ebi-2) und egd-1-ähnlicher gpcr
Duffy et al. Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies.
CA2220912A1 (fr) Facteur de croissance humain du type ccn
US20040096466A1 (en) Plasmodium falciparum antigens inducing protective antibodies
US5916769A (en) Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides
CA2242633A1 (fr) Facteur transformant de croissance alpha hiii
US6001806A (en) Interferon stimulating protein and uses thereof
JP2001500724A (ja) T1レセプター様リガンドii
CA2220670A1 (fr) Inhibiteur humain du gene 1 de l'apoptose
CA2446662A1 (fr) Facteur de virulence var o du plasmodium falciparum
WO2004037856A2 (fr) Facteur de virulence du var o du plasmodium falciparum
AU752206B2 (en) Extracellular/epidermal growth factor like protein
CA2249213A1 (fr) Proteine extracellulaire/epidermique de type facteur de croissance
US5928890A (en) Human amine receptor
US6294164B1 (en) Natural killer cell enhancing factor C
CA2224094A1 (fr) Recepteur d'amines humaines
AU716415B2 (en) Pineal gland specific gene-1
CA2221616A1 (fr) Hibef51, recepteur de proteines g humaines
JP2002514051A (ja) T1レセプター様リガンドi
CA2221821A1 (fr) Polypeptide de type iii activateur des monocytes et des cellules endotheliales
CA2210471A1 (fr) Chemokine humaine beta-11 et chemokine humaine alpha-1
CA2216912A1 (fr) Recepteur hdgnr10 de chimiokine de la proteine g humaine

Legal Events

Date Code Title Description
FZDE Discontinued